Skip to main content

ORIGINAL RESEARCH article

Front. Oncol.

Sec. Hematologic Malignancies

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1549809

A viral infection prediction model for r/r B-cell malignances patients after CAR-T therapy: a retrospective analysis

Provisionally accepted
Shujing Guo Shujing Guo 1Jile Liu Jile Liu 1Wang Bing Wang Bing 2Xiaomei Zhang Xiaomei Zhang 3Yifan Zhao Yifan Zhao 1Jianmei Xu Jianmei Xu 4Xinping Cao Xinping Cao 1Mohan Zhao Mohan Zhao 1Xia Xiao Xia Xiao 2*Mingfeng Zhao Mingfeng Zhao 2*
  • 1 Tianjin Medical University, Tianjin, China
  • 2 Tianjin First Central Hospital, Tianjin, China
  • 3 Nankai University, Tianjin, China
  • 4 Hebei University Affiliated Hospital, baoding, China

The final, formatted version of the article will be published soon.

    Background: Chimeric antigen receptor T cell (CAR-T) for relapsed/refractory (r/r) B cells acute lymphoblastic leukemia (B-ALL) and B cells non-Hodgkin lymphoma (B-NHL) patients has shown promising effects, but side effects such as viral infections have been observed.Methods: A total of 45 r/r B-ALL and r/r B-NHL patients were included in this retrospective study. Patient demographics were recorded, with the primary endpoint being viral infection within three months post CAR-T treatment. Univariate, multivariate logistic regression analysis, and lasso (95% CI 0.837-1.000) and 0.869 (95%CI 0.696-1.000) respectively, which had excellent predictive value.We established a nomogram to predict the factors influence on viral infection CAR-T and found that ratio of baseline lymphocyte and using G-CSF early or lately were screened to be able to predict viral

    Keywords: refractory/relapsed B cell malignances, chimeric antigen receptor T cells, predictive models, viral infection, Granulocyte Colony-Stimulating Factor

    Received: 22 Dec 2024; Accepted: 24 Feb 2025.

    Copyright: © 2025 Guo, Liu, Bing, Zhang, Zhao, Xu, Cao, Zhao, Xiao and Zhao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Xia Xiao, Tianjin First Central Hospital, Tianjin, China
    Mingfeng Zhao, Tianjin First Central Hospital, Tianjin, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more